cGMP signaling: a potential therapeutic target for neurodegeneration in glaucoma?
Main Authors: | Joseph M Holden, Lauren K Wareham |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=6;spage=1267;epage=1268;aulast=Holden |
Similar Items
-
cGMP Signaling in the Neurovascular Unit—Implications for Retinal Ganglion Cell Survival in Glaucoma
by: Ameer A. Haider, et al.
Published: (2022-11-01) -
cGMP Signaling in Photoreceptor Degeneration
by: Shujuan Li, et al.
Published: (2023-07-01) -
New Therapeutics for Heart Failure: Focusing on cGMP Signaling
by: Supachoke Mangmool, et al.
Published: (2023-08-01) -
Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice
by: Joseph M. Holden, et al.
Published: (2022-03-01) -
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
by: Elisabeth Schinner, et al.
Published: (2017-04-01)